Project

National MedTech Funding Mandate

Focus areas:
Locality:
National (Dorset and HIOW)
Compilation of images of people working in health and social care

The MedTech Funding Mandate (MTFM) is a NHS Long Term Plan commitment to get selected NICE-approved cost-saving devices, diagnostics and digital products to NHS patients more quickly.

The policy launched on 1 April 2021. The most recent guidance was issued in May 2024.

During 2025-26 we will be supporting AposHealth – to find out more, please read a case study from the NHS Innovation Service.

For more information on MTFM, or on the individual technologies, please get in touch.

Compilation of images of people working in health and social care

The MTFM supports devices, diagnostics or digital products that are:

  • effective and improve patient outcomes, demonstrated through positive NICE guidance
  • cost-saving within three years: NICE modelling demonstrates a net saving within three years of implementing the technology
  • affordable to the NHS: the budget impact should not exceed £20 million in any of the first three years.

It defines NICE-approved technologies that NHS commissioners and providers are mandated to agree local funding arrangements for, through their existing allocations. This is to ensure healthcare providers across England enable equitable access to patients.

The policy has three key objectives: 

  • ensure equity in healthcare provision is achieved by monitoring patient access to the supported technologies across the NHS in England
  • direct the NHS to the medical technology innovations that are most effective and likely to give savings on investment
  • support the NHS to develop a sustainable approach to overcoming the financial barriers to adopting medical devices, diagnostics and digital products.

The MTFM policy is an NHS England initiative, delivered with the support of the 15 Health Innovation Networks who work closely with their local systems. 

Technologies 

Technologies are added to the technology portfolio on a yearly basis. For 2025-26, we will be supporting AposHealth.

AposHealth  a non-invasive device worn on the feet to reduce pain and improve function in patients with knee osteoarthritis. The device consists of a pair of AposHealth shoes with two curved pods (pertupods) on the heel and forefoot of each shoe. The pertupods are securely attached to tracks on the bottom of the shoe with screws. Positioning of the pertupods is done by trained healthcare professionals and can be aided by gait analysis software or hardware.

AposHealth is recommended as a cost-saving treatment by NICE for patients who meet the criteria for joint replacement surgery and who have not responded adequately to the recommended NICE therapies.

If you are interested in learning more about Apos and the benefits it could bring to your service and system, then please contact us.



Useful links





Meet our Innovation adoption team

How can we help you?

If you’d like to get in touch please
email enquiries@hiwessex.net

More projects

See all projects

Case studies

See all case studies

Events

See all events

News

See all news

Videos & podcasts

See all videos & podcasts

Stay connected, sign up for
our monthly newsletter

Sign up now Funding newsletter